Company Filing History:
Years Active: 2011-2014
Title: Friedrich Bonhoeffer: Innovator in Nervous Tissue Research
Introduction
Friedrich Bonhoeffer is a notable inventor based in Tübingen, Germany. He has made significant contributions to the field of pharmaceutical compositions aimed at treating conditions related to vertebrate nervous tissue. With a total of 2 patents, his work focuses on innovative solutions for serious medical issues.
Latest Patents
Bonhoeffer's latest patents include the "Use of RGM and its modulators" and "Therapeutic use of antibodies directed against repulsive guidance molecule (RGM)." These inventions relate to the use of modulators of polypeptides for preparing pharmaceutical compositions. They aim to prevent, alleviate, or treat diseases associated with the degeneration or injury of nervous tissue, seizures, angiogenic disorders, and cardiovascular system issues. Additionally, his inventions address tumor growth and the formation of tumor metastases, highlighting their potential as markers for stem cells.
Career Highlights
Friedrich Bonhoeffer is affiliated with the Max Planck Society for the Advancement of Science. His work at this prestigious institution has allowed him to explore groundbreaking research in the field of nervous tissue and its associated disorders. His contributions have been instrumental in advancing our understanding of these complex medical challenges.
Collaborations
Bonhoeffer has collaborated with esteemed colleagues such as Bernhard K. Mueller and Philippe Patrick Monnier. These partnerships have enriched his research and expanded the impact of his inventions in the scientific community.
Conclusion
Friedrich Bonhoeffer's innovative work in the field of nervous tissue research has led to significant advancements in pharmaceutical compositions. His patents reflect a commitment to addressing critical health issues, making him a key figure in modern medical research.